biomedical sciences research institute - Research - University of Ulster

Dr Daniel BerrarLecturer in Biomedical SciencesBrief biography:Dr Daniel Berrar studied Medical Informatics at the University of Applied Sciences of Heilbronn (Germany), theUniversity of Heidelberg (Germany), and the University of Montreal (Canada). He received the BSc in MedicalInformatics from the University of Heidelberg in 1996 and the MSc in 1999. From July 2000 to January 2002, he wasconducting research in the Intelligent Bioinformatics Systems Group at the German Cancer Research Center inHeidelberg. In February 2002, he joined the Systems Biology Research Group at the School of Biomedical Sciences,Faculty of Life and Health Science, at the University of Ulster at Coleraine, Northern Ireland. He completed his Ph.D.in Bioinformatics in October 2004. From 2005 to 2007, Daniel Berrar worked as research fellow in the SystemsBiology Research Group at the University of Ulster. Since July 2007, he is lecturer in Biomedical Sciences at theUniversity of Ulster. In August 2008, Daniel was awarded a research fellowship by the Japanese Society for thePromotion of Science to conduct collaborative research from November 2008 to November 2010 with Dr HiroakiKitano at the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo.Main research activities in the period:• Research in the investigated areas.• Preparation, publication and presentation of research results.• Preparation of new research grant proposals.• Co-supervision of one PhD student.• Member of editorial board of one international journal.• Membership of four international program committees (IPC): CAMDA07, IDA07, IFIP AI08, DMIN08.• Networking with research institutes in the UK and Japan.• Design of module “Introduction to Statistics and Genomic Data Analysis using R” (BMS860).• Referee for 12 journals and 4 conferences.Dr Berrar is the named inventor for two patents filed during the reporting period:• United Kingdom Patent Application No. 0724131.8: Use of KIR genes for predicting response to therapy• United Kingdom Patent Application, No. 0821787.9: A genomic-based method of stratifying breast cancerpatients.Publications:Graham JE, Berrar D, McGilligan VE, Leccisotti A, Moore JE, Bron AJ, and Moore TCB; Attitudes towards diagnostictests and therapies for dry eye disease; Ophthalmic Research, accepted (2008)McCann MJ, Gill CI, Linton T, Berrar D, McGlynn H, Rowland IR; Enterolactone restricts the proliferation of theLNCaP human prostate cancer cell line in vitro; Mol Nutr Food Res, 52: 567-580, 2008Dr Chin-Kuo ChangLecturer in BiostatisticsDuring the period, Dr Chang’s study was accepted for presentation by poster in the annual meeting of AmericanSociety of Epidemiologic Research in Chicago in June with the abstract published in AJE:102